Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients

• The PROMIS Cancer Fatigue Short Form items loaded on a single factor.
• The scale demonstrated good internal consistency reliability in two samples of patients with cancer.
• Significant relationships with psychosocial measures offer evidence for convergent and concurrent validity.
• PROMIS Cancer Fatigue Short Form scores were higher in patients who met case definition criteria for cancer-related fatigue.
• The PROMIS Cancer Fatigue Short Form is a reliable and valid measure of fatigue in cancer patients.

ObjectiveFatigue is common among cancer patients and adversely impacts quality of life. As such, it is important to measure fatigue accurately in a way that is not burdensome to patients. The 7-item Patient Reported Outcome Measurement Information System (PROMIS) Cancer Fatigue Short Form scale was recently developed using item response theory (IRT). The current study evaluated the psychometric properties of this scale in two samples of cancer patients using classical test theory (CTT).MethodsTwo samples were used: 121 men with prostate cancer and 136 patients scheduled to undergo hematopoietic cell transplantation (HCT) for hematologic cancer. All participants completed the PROMIS Cancer Fatigue Short Form as well as validated measures of fatigue, vitality, and depression. HCT patients also completed measures of anxiety, perceived stress, and a clinical interview designed to identify cases of cancer-related fatigue.ResultsPROMIS Cancer Fatigue Short Form items loaded on a single factor (CFI = 0.948) and the scale demonstrated good internal consistency reliability in both samples (Cronbach's alphas > 0.86). Correlations with psychosocial measures were significant (p values < .0001) and in the expected direction, offering evidence for convergent and concurrent validity. PROMIS Fatigue scores were significantly higher in patients who met case definition criteria for cancer-related fatigue (p < .0001), demonstrating criterion validity.ConclusionThe current study provides evidence that the PROMIS Cancer Fatigue Short Form is a reliable and valid measure of fatigue in cancer patients.